Paid Clinical Trials for Glioblastoma (GBM)

Login to your account

Reset Password

Please Enter Username or Email

Create a free account

I'm a Participant
I'm an Organization

Showing all 6 results

A Phase 1 Study of the Safety and Tolerability of MT-125 in GBM Patients

by CTG

in Glioblastoma (GBM)

Other

Arizona

Deadline:

06/01/2027

Study of Low-Intensity Focused Ultrasound in Combination With Immunotherapy in Newly Diagnosed Unmethylated Glioblastoma

by CTG

in Glioblastoma (GBM)

Other

Virginia

Deadline:

12/01/2028

A Phase 0/1 Clinical Trial With an Expansion Phase of GSK5764227, a B7-H3-Targeted Antibody-Drug Conjugate (ADC), in Patients With Recurrent Grade 4 Glioma and Patients With Brain Metastases

by CTG

in Glioblastoma (GBM), Brain Metastasases

Other

Arizona

Deadline:

07/01/2029

Enhanced Local Intensified Radiation Therapy in Elderly Glioblastoma: A Phase 2 Hybrid Randomized Trial

by CTG

in Glioblastoma (GBM)

Other

Massachusetts

Deadline:

03/31/2029

Intrathecal Azacitidine and Nivolumab in Patients With Recurrent High-grade Glioma

by CTG

in Glioblastoma (GBM), Diffuse Hemispheric Glioma, H3 G34-mutant, Astrocytoma, IDH-Mutant, Grade 4, Gliosarcoma of Brain, Diffuse Midline Glioma (DMG)

Other

Iowa

Deadline:

03/01/2027

A Phase IB 2 Dose Trial of IRS-1 HSV C134 (IND 17296) Administered Intratumorally in Patients with Recurrent Malignant Glioma

by CTG

in Astrocytoma, Grade III, Astrocytoma, Grade IV, Glioblastoma (GBM), Astrocytoma, Glioblastoma

Other

Alabama

Deadline:

01/01/2027